on (#6K5XQ)
This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants.
Link | https://www.cdc.gov/mmwr/index.html |
Feed | http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5 |
Updated | 2025-07-05 18:01 |